InsiderTrades

Form 4 for TECH Bio-Techne

Accepted 2023-08-08 00:00:00 ET · period of report 2023-08-05 · accession 0001062993-23-016038 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-08-08 2023-08-05 TECH Hippel James CFO F - Tax $82.17 -6,335 57.6K -10% -$520.5K
D 2023-08-08 2023-08-05 TECH Hippel James CFO M - OptEx $0.00 +12.9K 63.9K +25% $0
D 2023-08-08 2023-08-05 TECH Hippel James CFO M - OptEx $0.00 -12.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-05 F D 6,335 $82.17 57,561 D — —
2 Common Common Stock 2023-08-05 M A 12,876 $0.00 63,896 D — —
3 Derivative Restricted Stock Units 2023-08-05 M D 12,876 $0.00 0 D — · — to — 12,876 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F3) On 8/5/2023, the Board of Directors certified vesting of 12,876 performance RSUs.